- Home
- GRML vs NUR Comparison
GRML vs NUR Comparison
Compare GRML & NUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Company Overview
Basic Information| Metric | GRML | NUR |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.2M | 25.2M |
| IPO Year | 2022 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GRML | NUR |
|---|---|---|
| Price | $4.82 | $1.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 38.1K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 31.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $1.74 |
| 52 Week High | $11.66 | $2.29 |
Technical Indicators
Market Signals| Indicator | GRML | NUR |
|---|---|---|
| Relative Strength Index (RSI) | 60.60 | N/A |
| Support Level | $0.20 | N/A |
| Resistance Level | $11.66 | N/A |
| Average True Range (ATR) | 0.60 | 0.00 |
| MACD | 0.15 | 0.00 |
| Stochastic Oscillator | 39.44 | 0.00 |
Price Performance
Historical Comparison GRML
NUR
About GRML Greenland Mines Ltd. Common Stock
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.